761
Views
127
CrossRef citations to date
0
Altmetric
Original Article

Processing difficulties and instability of carbohydrate microneedle arrays

, , , , , & show all
Pages 1242-1254 | Received 05 Feb 2009, Accepted 09 Mar 2009, Published online: 08 May 2009

References

  • Henry S, McAllister DV, Allen MG, Prausnitz MR. (1998). Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci, 87:922–5.
  • Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56:581–87.
  • Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD. (2004). Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release, 97:503–11.
  • Mikszta JA, Dekker JP, Harvey NG, Dean CH, Brittingham JM, Huang J. (2006). Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun, 74:6806–10.
  • Coulman SA, Barrow D, Anstey A, Gateley C, Morrissey A, Wilke N. (2006). Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Deliv, 3:65–75.
  • McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG. (2003). Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci USA, 100:13755–60.
  • Xie Y, Xu B, Gao Y. (2005). Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine, 1:184–90.
  • Park JH, Allen MG, Prausnitz MR. (2005). Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery. J Control Release, 104:51–66.
  • Park JH, Allen MG, Prausnitz MR. (2006). Polymer microneedles for controlled-release drug delivery. Pharm Res, 23:1008–19.
  • Gardeniers JGE, Luttge R, Berenschot EJW. (2003). Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromech Syst, 12:855–62.
  • Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR. (2004). Transdermal delivery of insulin using microneedles in vivo. Pharm Res, 21:947–52.
  • Nordquist L, Roxhed N, Griss P, Stemme G. (2007). Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: An initial comparison with subcutaneous administration. Pharm Res, 24:1381–8.
  • Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci, 29:82–8.
  • Ito Y, Yoshimitsu J, Shiroyama K, Sugioka N, Takada K. (2006). Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target, 14:255–61.
  • Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, (2002). Macroflux microprojection array patch technology: A new and efficient approach for intracutaneous immunization. Pharm Res, 19:63–70.
  • Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE. (2006). Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine, 24:1653–64.
  • Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. (2002). Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med, 8:415–9.
  • Teo MA, Shearwood C, Ng KC, Lu J, Moochhala S. (2005). In vitro and in vivo characterization of MEMS microneedles. Biomed Microdevices, 7:47–52.
  • Wang PM, Cornwell M, Hill J, Prausnitz MR. (2006). Precise microinjection into skin using hollow microneedles. J Invest Dermatol, 126:1080–7.
  • Davis SP, Martanto W, Allen MG, Prausnitz MR. (2005). Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng, 52:909–15.
  • Schuetz YB, Naik A, Guy RH. (2005). Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv, 2:533–48.
  • Miyano T, Tobinaga Y, Kanno T, Matsuzaki Y, Takeda H, Wakui M, (2005). Sugar micro needles as transdermic drug delivery system. Biomed Microdevices, 7:185–8.
  • Miyano T, Miyachi T, Okanishi T, Todo H, Sugibayashi K, Uemura T, (2007). Hydrolytic microneedles as transdermal drug delivery system. Transducers, 1:355–8. Proceedings of the 14th International Conference on Solid-State Senors, Actuators and Microsystems, Lyon, France, June 10–14
  • Kolli CS, Banga AK. (2008). Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res, 25:104–13.
  • Wilke N, Mulcahy A, Ye SR, Morrissey A. (2005). Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectronics J, 36:650–6.
  • Johnson ME, Berk DA, Blankschtein D, Golan DE, Rakesh KJ, Langer RS. (1996). Lateral diffusion in human stratum corneum and model lipid bilayer system. Biophys J, 71:2656–68.
  • Donnelly RF, Morrow DIJ, McCarron PA, Juzenas P, Woolfson AD. (2006). Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues. J Photochem Photobiol B, 82:59–71.
  • Shabir GA. (2003). Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US food and drug administration, the US Pharmacopoeia and the International Conference on Harmonization. J Chromatogr A, 987:57–66.
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. (1996) .ICH-Topic Q2B: Validation of Analytical Procedures: Methodology, Geneva, Switzerland.
  • McCarron PA, Woolfson AD, Donnelly RF, Andrews GP, Zawislak A, Price JH. (2004). Influence of plasticiser type and storage conditions on the properties of poly(methyl vinyl ether-co-maleic anhydride) bioadhesive films. J Appl Polym Sci, 91:1576–89.
  • Seo J, Oh J, Kim DJ, Kim HK, Hwang Y. (2004). Making monosaccharide and disaccharide sugar glasses by using microwave oven. J Non-Cryst Solids, 333:111–4.
  • Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. (2007). Sustained-release self-dissolving micropiles for percutaneous absorption of insulin in mice. J Drug Target, 15:323–6.
  • Yaylayan AV. (1997). Classification of the Millard reaction: A conceptual approach. Trends Food Sci Technol, 8:13–8.
  • Cilurzo F, Minghetti P, Sinico C. (2007). Newborn pig skin as model membrane in in vitro drug permeation studies: A technical note. AAPS PharmSciTech, 8:E1–3.
  • Simon GA, Maibach HI. (2000). The pig as an experimental animal model of percutaneous permeation in man: Qualitative and quantitative observations—An overview. Skin Pharmacol Appl Skin Physiol, 13(5):229–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.